Volitionrx Limited (VNRX) to Offer Common Stock

VolitionRx Limited (NYSE: VNRX) intends to offer and sell shares of its common stock in an underwritten public offering. Volition intends to grant the underwriters a 30-day option to purchase additional shares of its common stock sold in the offering, to cover overallotments, if any. All shares of common stock in the offering are being offered by Volition. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

National Securities Corporation, a wholly owned subsidiary of National Holdings Corporation (NASDAQ: NHLD), is acting as sole book-running manager in connection with the offering.

Volition intends to use the net proceeds of the offering for continued product development, clinical studies, product commercialization, working capital, and other general corporate purposes, including potential strategic acquisitions.

You May Also Be Interested In

• Erasca closes $632.5M public offering of common stock
• Jones Ventures INTL Acquisition1 closes $200M IPO on Nasdaq
• AST SpaceMobile prices $1 billion convertible notes offering due 2034